|
Ponezheva Z.B., Grishaeva А.А., Alimova L.K., Burdakova E.A., Makashova V.V., Krasnova S.V.
Clinical and laboratory characteristics of severe forms of new coronavirus infection
|
№3 / 2022
|
|
Malysheva V.A., Guryanova E.A., Tyurnikova S.R., Simunov Yu.L., Dmitrieva A.N., Peskov D.A., Vorontsov D.S.
Gender differences in patients after COVID pneumonia at the third stage of rehabilitation
|
№2 (приложение) / 2022
|
|
Karateev A.E.
Rheumatological problems with COVID-19: from arthralgia to rheumatoid arthritis
|
№2 / 2022
|
|
Zakharov V.V., Gromova D.O.
Neurological manifestations of post-covid syndrome
|
№1 / 2022
|
|
Grigorieva E.V., Bogdalova L.R.
SARS-CoV-2 infection in the patient with kidney transplant
|
№1 / 2022
|
|
Izmozherova N.V., Popov A.A., Shambatov M.A., Baksheev I.Yu.
Smell and taste impairment in young adults with COVID-19
|
№1 / 2022
|
|
Kokorin V.A.
Acetylsalicylic acid in the treatment of patients with new coronavirus infection (COVID-19): pro and contra
|
№10 / 2021
|
|
Vakhlevsky V.V., Tyrenko V.V., Bologov S.G., Kryukov E.V., Toporkov M.M.
The role of interferon gamma in novel coronavirus infection pathogenesis and the possibilities of immune response correction
|
№10 / 2021
|
|
Vasenina E.E., Veryugina N.I., Levin O.S.
Post-infectious asthenia and COVID-19
|
№9 / 2021
|
|
Resolution of the Council of experts on scientific experience exchange of antiplatelet drugs use, including acetylsalicylic acid for prevention of COVID-19 arterial vascular complications in different time periods of the disease
|
№9 / 2021
|
|
Yanushevich O.O., Levchenko O.V., Semenyakin I.V., Solodov A.A., Kebina A.L., Sycheva A.S., Grigorieva E.V., Pogosyan R.R.
Spontaneous pneumomediastinum in patients with COVID-19 pneumonia
|
№9 / 2021
|
|
Nevzorova V.A., Bondareva Zh.V., Potapova E.S., Egorova D.V.
Issues of immunoprophylaxis in the practice of a general practitio
|
№8 / 2021
|
Русский
